Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method.

"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Ralf Gold has received research support and speaker’s honoraria from Bayer Schering, Biogen, Bristol Myers Squibb, Chugai, Eisai, Janssen, Merck Serono, Nikkiso Pharma, Novartis, Roche, Sanofi Genzyme and TEVA; and consulting honoraria from ZLB Behring, Baxter, Merck, MIMS and Talecris. He holds personal stock options in Bayer, Merck, Novartis and Roche. Dr Michael Barnett has received institutional support for research or speaking from Alexion, Biogen, Merck, Roche, BMS and Sanofi Genzyme; is Research Director, Sydney Neuroimaging Analysis Centre and Research Consultant, RxMx. Dr Andrew Chan has received speakers’/board honoraria from Actelion (Janssen/Johnson & Johnson), Alexion, Almirall, Bayer, Biogen, Bristol Myers Squibb (Celgene), Genzyme, Merck KGaA (Darmstadt, Germany), Novartis, Roche and Teva, all for hospital research funds. Beyond this project, Dr Huiyu Feng has no further disclosures. Dr Kazuo Fujihara serves as an advisor or on scientific advisory boards for Biogen, Mitsubishi Tanabe, Novartis, Chugai/Roche, Alexion, VielaBio/Horizon Therapeutics, UCB, Merck Biopharma, Japan Tobacco and AbbVie; has received funding for travel and speaker honoraria from Biogen, Eisai, Mitsubishi Tanabe, Novartis, Chugai, Roche, Alexion, VielaBio, Teijin, Asahi Kasei Medical, Merck and Takeda and has received the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Grants-in-Aid for Scientific Research from the Ministry of Health, Welfare and Labour of Japan. In the last 2 years, Dr Gavin Giovannoni has received compensation for serving as a consultant or speaker for or has received research support from AbbVie, Aslan, Atara Bio, Biogen, Bristol Myers Squibb (Celgene), GlaxoSmithKline, Janssen/J&J, Japan Tobacco, Jazz Pharmaceuticals, LifNano, Merck & Co, Merck KGaA/EMD Serono, Moderna, Novartis, Sanofi and Roche/Genentech. In the last 5 years, Dr Giovannoni has received grant support for research from Biogen, Merck KGaA/EMD Serono, Novartis, Sanofi, Roche/Genentech and Takeda. Dr Xavier Montalbán has received speaking honoraria and travel expenses for participation in scientific meetings, has been a Steering Committee member of clinical trials or participated in advisory boards of clinical trials in the past years with AbbVie, Actelion, Alexion, Biogen, Bristol Myers Squibb (Celgene), EMD Serono, Genzyme, Hoffmann-La Roche, Immunic Therapeutics, Janssen, MedDay, Merck, Mylan, Nervgen, Novartis, Sandoz, Sanofi Genzyme, Teva Pharmaceuticals, TG Therapeutics, Excemed, Multiple Sclerosis International Federation and National Multiple Sclerosis Society. Beyond this project, Dr Fu-Dong Shi has no further disclosures. Dr Mar Tintoré has received compensation for consulting services, speaking honoraria and research support from Almirall, Bayer Schering Pharma, Biogen-Idec, Genzyme, Janssen, Merck Serono, Novartis, Roche, Sanofi-Aventis, Viela Bio and Teva Pharmaceuticals and participates on the Data Safety Monitoring Boards for Parexel and UCB Biopharma. Beyond this project, Dr Qun Xue has no further disclosures. Beyond this project, Dr Chunsheng Yang has no further disclosures. Beyond this project, Dr Hongyu Zhou has no further disclosures."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This Steering Committee initiative was sponsored by Biogen. Writing and editorial assistance was funded by Biogen and provided by MIMS (Hong Kong and Pte) Limited."